<p>CDT Equity Inc. 宣布向 Corvus Capital Limited 发行 224,800 股普通股和 3,685,815 份预先融资的认股权证，作为其子公司 Conduit Pharmaceuticals Limited 出售的相关交易。该交易的估值为 7,000,000 美元，结构为私募，证券的发行依据 1933 年证券法第 4(a)(2) 条的注册豁免进行。所发行的股票和认股权证受到转售限制，未经注册或适用的豁免，不得在美国提供或出售。预先融资认股权证的行使需遵循纳斯达克规则下的股东批准。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。CDT Equity Inc. 于 2025 年 12 月 12 日通过美国证券交易委员会（Ref. ID: 0001493152-25-027489）运营的电子数据收集、分析和检索系统 EDGAR 发布了用于生成本新闻简报的原始内容，并对此信息的准确性承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里</p>

<p>CDT Equity Inc. 已向 Corvus Capital Limited 发行了 224,800 股普通股和 3,685,815 份预先融资认股权证，融资金额为 700 万美元的私募。该交易与其子公司 Conduit Pharmaceuticals Limited 的出售有关。这些证券是在注册豁免下发行的，并受到转售限制。根据纳斯达克规则，行使认股权证需要股东批准</p>

<p>CDT Equity Inc. has announced the issuance of 224,800 shares of common stock and 3,685,815 pre-funded warrants to Corvus Capital Limited in connection with the sale of its subsidiary, Conduit Pharmaceuticals Limited. The transaction, valued at $7,000,000, was structured as a private placement and the securities were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933. The issued shares and warrants are subject to restrictions on resale and may not be offered or sold in the United States without registration or an applicable exemption. The exercise of the pre-funded warrants is subject to stockholder approval under Nasdaq rules. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CDT Equity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-027489), on December 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>
<div class="lb-trans"><p>CDT Equity Inc. 宣布向 Corvus Capital Limited 发行 224,800 股普通股和 3,685,815 份预先融资的认股权证，作为其子公司 Conduit Pharmaceuticals Limited 出售的相关交易。该交易的估值为 7,000,000 美元，结构为私募，证券的发行依据 1933 年证券法第 4(a)(2) 条的注册豁免进行。所发行的股票和认股权证受到转售限制，未经注册或适用的豁免，不得在美国提供或出售。预先融资认股权证的行使需遵循纳斯达克规则下的股东批准。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。CDT Equity Inc. 于 2025 年 12 月 12 日通过美国证券交易委员会（Ref. ID: 0001493152-25-027489）运营的电子数据收集、分析和检索系统 EDGAR 发布了用于生成本新闻简报的原始内容，并对此信息的准确性承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里</p>
</div>

CDT Equity Inc.在 700 万美元的私募中发行了股票和预融资认股权证